Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Haematol ; 104(1): 15-25, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31661175

ABSTRACT

Bleeding related to portal hypertension and coagulopathy is a common complication in patients with cirrhosis. Complications and management of bleeding is a significant source of healthcare cost and utilization, as well as morbidity and mortality. Due to the scarcity of evidence surrounding transfusion strategies and hemostatic interventions in patients with cirrhosis, there has been significant debate regarding the best practice. Emerging data suggest that evidence supporting transfusion of packed red blood cells to a hemoglobin threshold of 7-8 g/dL is strong. thrombopoietin (TPO) receptor agonists have shown promise in increasing platelet levels and reducing transfusions preprocedurally, although have not specifically been found to reduce bleeding risk. Data for viscoelastic testing (VET)-guided transfusions appear favorable for reducing blood transfusion requirements prior to minor procedures and during orthotopic liver transplantation. Hemostatic agents such as recombinant factor VIIa, prothrombin complex concentrates, and tranexamic acid have been examined but their role in cirrhotic patients is unclear. Other areas of growing interest include balanced ratio and whole blood transfusion. In the following manuscript, we summarize the most up to date evidence for threshold-guided, VET-guided, balanced-ratio, and whole blood transfusions as well as the use of hemostatic agents in cirrhotic patients to provide practice guidance to clinicians.


Subject(s)
Blood Coagulation Factors/therapeutic use , Erythrocyte Transfusion , Factor VIIa/therapeutic use , Hemorrhage , Hypertension, Portal , Liver Cirrhosis , Hemorrhage/blood , Hemorrhage/etiology , Hemorrhage/therapy , Humans , Hypertension, Portal/blood , Hypertension, Portal/etiology , Hypertension, Portal/therapy , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Liver Cirrhosis/therapy , Practice Guidelines as Topic , Receptors, Thrombopoietin/agonists , Receptors, Thrombopoietin/blood , Recombinant Proteins/therapeutic use
2.
Transfusion ; 55(6): 1331-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25823522

ABSTRACT

BACKGROUND: The Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial was a randomized clinical trial comparing survival after transfusion of two different blood component ratios for emergency resuscitation of traumatic massive hemorrhage. Transfusion services supporting the study were expected to provide thawed plasma, platelets, and red blood cells within 10 minutes of request. STUDY DESIGN AND METHODS: At the 12 Level 1 trauma centers participating in PROPPR, blood components transfused and delivery times were tabulated, with a focus on universal donor (UD) plasma management. The adequacy of site plans was assessed by comparing the bedside blood availability times to study goals and the new American College of Surgeons guidelines. RESULTS: Eleven of 12 sites were able to consistently deliver 6 units of thawed UD plasma to their trauma-receiving unit within 10 minutes and 12 units in 20 minutes. Three sites used blood group A plasma instead of AB for massive transfusion without complications. Approximately 4700 units of plasma were given to the 680 patients enrolled in the trial. No site experienced shortages of AB plasma that limited enrollment. Two of 12 sites reported wastage of thawed AB plasma approaching 25% of AB plasma prepared. CONCLUSION: Delivering UD plasma to massively hemorrhaging patients was accomplished consistently and rapidly and without excessive wastage in high-volume trauma centers. The American College of Surgeons Trauma Quality Improvement Program guidelines for massive transfusion protocol UD plasma availability are practicable in large academic trauma centers. Use of group A plasma in trauma resuscitation needs further study.


Subject(s)
Blood Component Transfusion , Hemorrhage/therapy , Multicenter Studies as Topic/statistics & numerical data , Plasma , Randomized Controlled Trials as Topic/statistics & numerical data , Wounds and Injuries/complications , ABO Blood-Group System/blood , Blood Banks/statistics & numerical data , Blood Component Transfusion/statistics & numerical data , Blood Preservation , Cryopreservation , Female , Hemorrhage/etiology , Humans , Male , Resuscitation , Time Factors , Trauma Centers/statistics & numerical data , United States , Blood Banking/methods
4.
J Surg Res ; 124(1): 3-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15734472

ABSTRACT

HYPOTHESIS: Extra-abdominal injury negatively affects the outcome of abdominal injury following trauma laparotomy. DESIGN: Retrospective review of 920 consecutive patients receiving laparotomy for trauma who survived more than 24 h between January 1989 and May 1998 at a Level 1 trauma center. Major abdominal complications (MAC) were defined as: abdominal compartment syndrome (ACS), abscess/peritonitis, enterocutaneous fistula, necrotizing fasciitis, and necrotizing pancreatitis. METHODS: Univariant and multivariant logistic regression were used to identify predictors of MAC. RESULTS: Sixty-nine patients (7.5%) developed one or more MAC. Patients who developed MAC had higher injury severity scores (ISS), abdominal trauma indices (ATI), and blood transfusions in the first 24 h (PRCs) than patients who did not develop MAC. Patients with MAC were more likely to have suffered a thoracic or pelvic injury with an abbreviated injury scale (AIS) > or =3 and were more likely to have received an extremity injury (AIS > or =3) operation than patients without MAC. Independent predictors of MAC in multivariant analysis included colon injury (AIS > or =3) [odds ratio (OR) = 3.1, 95% confidence interval (CI) 1.5- 6.3)], pelvic injury (AIS > or =3) or operation for extremity injury (AIS > or =3) [OR 2.9, 95% CI 1.5-5.3], and ATI (OR = 1.03 for each 10 unit increase in ATI, 95% CI 1.02-1.05). PRCs did not independently predict MAC. CONCLUSION: The outcome of laparotomy for trauma (both blunt and penetrating) is negatively affected by a severe pelvic injury or a severe extremity injury operation independent of initial hemorrhage and abdominal injury severity.


Subject(s)
Abdominal Injuries/epidemiology , Laparotomy , Multiple Trauma/epidemiology , Postoperative Complications , Abdominal Injuries/complications , Adolescent , Adult , Extremities/injuries , Female , Humans , Male , Middle Aged , Multiple Trauma/complications , Oregon/epidemiology , Pelvic Bones/injuries , Pelvis/injuries , Retrospective Studies , Treatment Outcome
5.
Fertil Steril ; 84(1): 212-6, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16009179

ABSTRACT

OBJECTIVE: To assess histologic damage and functional impairment following coaxial tubal catheterization. DESIGN: Prospective randomized controlled study. SETTING: Research laboratory. PATIENT(S): Ninety-two female New Zealand rabbits. INTERVENTION(S): Tubal cannulation and mating. MAIN OUTCOME MEASURE(S): Rabbits randomized for placement of unilateral catheter and guide wire (group 1), unilateral catheter and guide wire plus falloposcope (group 2), and catheterization as in group 1 or 2 but using a cage catheter (groups 3 and 4, respectively). A fifth group consisted of rabbits with tubal perforations. Rabbits were killed at 2 or 4 weeks after catheterization or after mating. The sixth group consisted of only control rabbits. RESULT(S): Only one catheterized tube in groups 1 and 3 showed inflammation, fibrosis, or edema. None of the tubes manifested ciliary loss. Serosal tubal adhesions were identified in two tubes in group 1, in one in group 3, in three tubes in group 5, and one in the control group. The nidation index in control and nonperforated catheterized tubes ranged from 72%-95% (not significant). Nidation index in tubes unintentionally perforated was 81%. CONCLUSION(S): Catheterization of the uterotubal junction and fallopian tube in rabbits does not cause long-term tubal damage or impair tubal function.


Subject(s)
Catheterization/instrumentation , Catheterization/methods , Fallopian Tubes/anatomy & histology , Fallopian Tubes/physiology , Animals , Fallopian Tube Patency Tests/instrumentation , Fallopian Tube Patency Tests/methods , Female , Pregnancy , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL